StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)

Close on Nov 17, 2026Market cap $41.33MP/E –Yield –

Harvard Bioscience enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Harvard Bioscience's enterprise value was $74.25M on Nov 11, 2026, against $27.11M a year earlier. Over the last 5 years it ranged from $12.08M to $327.65M, with a median of $156.14M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$74.25M+222.8%
2025Dec 31, 2025$23.00M-81.7%
2024Dec 31, 2024$125.71M-52.0%
2023Dec 29, 2023$262.07M+64.0%
2022Dec 30, 2022$159.78M-51.2%
2021Dec 31, 2021$327.65M+57.3%
2020Dec 31, 2020$208.26M+29.4%
2019Dec 31, 2019$160.96M-6.0%
2018Dec 31, 2018$171.16M+43.9%
2017Dec 29, 2017$118.94M+6.0%
2016Dec 30, 2016$112.16M-11.6%
2015Dec 31, 2015$126.85M-27.5%
2014Dec 31, 2014$175.04M+21.1%
2013Dec 31, 2013$144.51M+17.0%
2012Dec 31, 2012$123.56M+17.1%
2011Dec 30, 2011$105.55M-0.0%
2010Dec 31, 2010$105.59M–

More Harvard Bioscience figures

See a number that looks wrong?